Asthma

Kaleo set to relaunch withdrawn Epipen rival Auvi-Q next year

update - Kaleo wants all patients to have access to Auvi-Q, regardless of insurance coverage

Kaleo set to relaunch withdrawn Epipen rival Auvi-Q next year

By Gareth Macdonald

Kaleo has said it will relaunch Auvi-Q (epinephrine injection) a year after a recall by licensee Sanofi removed the Epipen rival from the market.